2023 Promise Ball Honoree Named




Jon Muskrat



Breakthrough T1D Greater CT/Western MA Announces Jeff Hamilton as 2023 Star of Hope Award Recipient


(Farmington, Conn., February 6, 2023) – Breakthrough T1D Greater CT/Western MA is pleased to announce that Jeff Hamilton, President and General Manager, Mohegan Sun, will be honored with the Star of Hope award at the 2023 Promise Ball. Mr. Hamilton was chosen for his passionate commitment to Breakthrough T1D’s mission of accelerating life-changing breakthroughs to cure, prevent and treat type 1 diabetes (T1D) and its complications.

Mr. Hamilton accepted the opportunity to serve on the Breakthrough T1D Board of Directors for the Greater Connecticut & Western Massachusetts Chapter in July 2022.

“I am honored to receive this award at the 2023 Breakthrough T1D Promise Ball,” said Hamilton. “As someone living with T1D, as well as having a daughter with Type 1, Breakthrough T1D is an organization I am proud to support.  I am deeply moved by the strength of the T1D community as well as those who are directly impacted by the funds raised through this event. We are looking forward to hosting everyone at Mohegan Sun.”

The 2023 Breakthrough T1D Promise Ball will be held on Saturday, May 6th at Mohegan Sun.  For more information about the 2022 Promise Ball, please visit https://jdrf-greater-ct-western-ma.ejoinme.org/


About Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that impacts millions of people around the world. The disease occurs when the body’s immune system attacks and destroys the beta cells in the pancreas that produce insulin, a hormone essential to turning food into energy. Without insulin, glucose from food stays in the blood, where it can cause serious damage to all of the body’s organ systems. It requires constant carbohydrate counting, blood-glucose testing, and lifelong dependence on injected insulin. With T1D there are no days off, and there is no cure.

About Breakthrough T1D
Breakthrough T1D is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, Breakthrough T1D has invested nearly $2 billion since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in Breakthrough T1D Greater CT/Western MA, and in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org.